Tris Pharma Announces FDA Approval of DYANAVEL® XR (amp

/PRNewswire/ -- Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release...

Related Keywords

Tri Liqui , James Hackworth , Andrewj Cutler , Tris Pharma Inc , Prnewswire Tris Pharma Inc , Drug Administration , Neuroscience Education Institute , Tris Branded Products Division , Attention Deficit Hyperactivity Disorder , Permanent Product Measure , Performance Total , Clinical Associate Professor , Tris Branded Products , Full Prescribing Information , Boxed Warning , New Jersey Based , Tris Pharma , Nc ,